Rider DA, Eisermann M, Loffler K, Aleku M, et al. Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease. Atherosclerosis 2022;349:240-247.
PMID: 35400495